NIOX Group (LON:NIOX) Announces Earnings Results

NIOX Group (LON:NIOX) announced its quarterly earnings results on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%.

NIOX Group Stock Up 1.2%

Shares of LON:NIOX traded up GBX 0.80 during midday trading on Friday, reaching GBX 66.80. 175,685 shares of the company were exchanged, compared to its average volume of 796,137. The firm has a market cap of £281.14 million, a PE ratio of 40.73 and a beta of 0.92. NIOX Group has a fifty-two week low of GBX 53.84 and a fifty-two week high of GBX 76. The stock has a fifty day simple moving average of GBX 65.81 and a two-hundred day simple moving average of GBX 61.71. The company has a quick ratio of 1.94, a current ratio of 4.60 and a debt-to-equity ratio of 1.06.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.